Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseSummary

Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel DiseaseSummary

Background & Aims: Altered plasma acylcarnitine levels are well-known biomarkers for a variety of mitochondrial fatty acid oxidation disorders and can be used as an alternative energy source for the intestinal epithelium when short-chain fatty acids are low. These membrane-permeable fatty ac...

Full description

Bibliographic Details
Main Authors: Johanna M.S. Lemons, Maire Conrad, Ceylan Tanes, Jie Chen, Elliot S. Friedman, Manuela Roggiani, Dylan Curry, Lillian Chau, Aaron L. Hecht, Lisa Harling, Jennifer Vales, Kelly E. Kachelries, Robert N. Baldassano, Mark Goulian, Kyle Bittinger, Stephen R. Master, LinShu Liu, Gary D. Wu
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Cellular and Molecular Gastroenterology and Hepatology
Subjects:
Microbiota
IBD
Metabolism
Carnitine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352345X23001674

Similar Items

Similar Items